|Mr. Florian Schönharting||Co-Founder & Chairman||N/A||N/A||1969|
|Dr. Claus Bo Svendsen||CEO & Principal Financial Officer||N/A||N/A||1977|
|Mr. Thomas Carbone||Principal Accounting Officer||N/A||N/A||1957|
Forward Pharma A/S operates as a biopharmaceutical company. The company focuses on developing FP187, a proprietary formulation of dimethyl fumarate used for the treatment of various inflammatory and neurological indications. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.
Forward Pharma A/S’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.